skip to main content
DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Bioluminescence methods for enzymatic determinations

Abstract

An enzymatic method for continuous, on-line and rapid detection of diagnostically useful biomarkers, which are symptomatic of disease or trauma-related tissue damage, is disclosed. The method is characterized by operability on authentic samples of complex biological fluids which contain the biomarkers.

Inventors:
 [1];  [2];  [3]
  1. (Oak Ridge, TN)
  2. (Clinton, TN)
  3. (Norris, TN)
Issue Date:
Research Org.:
Oak Ridge National Laboratory (ORNL), Oak Ridge, TN
OSTI Identifier:
864379
Patent Number(s):
4357420
Assignee:
United States of America as represented by United States (Washington, DC) ORNL
Resource Type:
Patent
Country of Publication:
United States
Language:
English
Subject:
bioluminescence; methods; enzymatic; determinations; method; continuous; on-line; rapid; detection; diagnostically; useful; biomarkers; symptomatic; disease; trauma-related; tissue; damage; disclosed; characterized; operability; authentic; samples; complex; biological; fluids; contain; rapid detection; tissue damage; biological fluids; biological fluid; enzymatic method; diagnostically useful; /435/422/

Citation Formats

Bostick, William D., Denton, Mark S., and Dinsmore, Stanley R. Bioluminescence methods for enzymatic determinations. United States: N. p., 1982. Web.
Bostick, William D., Denton, Mark S., & Dinsmore, Stanley R. Bioluminescence methods for enzymatic determinations. United States.
Bostick, William D., Denton, Mark S., and Dinsmore, Stanley R. Fri . "Bioluminescence methods for enzymatic determinations". United States. https://www.osti.gov/servlets/purl/864379.
@article{osti_864379,
title = {Bioluminescence methods for enzymatic determinations},
author = {Bostick, William D. and Denton, Mark S. and Dinsmore, Stanley R.},
abstractNote = {An enzymatic method for continuous, on-line and rapid detection of diagnostically useful biomarkers, which are symptomatic of disease or trauma-related tissue damage, is disclosed. The method is characterized by operability on authentic samples of complex biological fluids which contain the biomarkers.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {1982},
month = {1}
}

Patent:

Save / Share: